The research significance of concomitant use of CAR-CD138-NK and CAR-CD19-NK to target multiple myelomas
Author:
Affiliation:
1. The Cyrus Tang Hematology Center, Soochow University, Suzhou, P.R. China
2. Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China
3. PersonGen BioTherapeutics (Suzhou) Co., Ltd, Suzhou, P.R. China
Abstract
Funder
Priority Academic Program Development of Jiangsu Higher Education Institutions
Shandong Provincial Natural Science Foundation
the Six Talent Peaks Project in Jiangsu Province
the National Natural Science Foundation of China
the Collaborative Innovation Major Project
Publisher
SAGE Publications
Link
http://journals.sagepub.com/doi/pdf/10.1177/2058739218788968
Reference24 articles.
1. Global cancer statistics
2. Innate or Adaptive Immunity? The Example of Natural Killer Cells
3. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
4. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
5. Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges;International Immunopharmacology;2022-09
2. Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects;Stem Cell Reviews and Reports;2021-09-02
3. Surface specifically modified NK-92 cells with CD56 antibody conjugated superparamagnetic Fe3O4 nanoparticles for magnetic targeting immunotherapy of solid tumors;Nanoscale;2021
4. Role of cell surface proteoglycans in cancer immunotherapy;Seminars in Cancer Biology;2020-05
5. Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation;Advances in Experimental Medicine and Biology;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3